Dealing with ceiling baseline treatment satisfaction level in patients with diabetes under flexible, functional insulin treatment: Assessment of improvements in treatment satisfaction with a new insulin analogue

Quality of Life Research

Volumn 9, Issue 8, 2000, Pages 915-930

  Howorka, K ^a   Pumprla, J ^a   Schlusche, C ^a   Wagner Nosiska, D ^a   Schabmann, A ^b   Bradley, C ^c  

^a Research Group on Functional Rehabilitation and Group Education   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Diabetes mellitus; Functional insulin treatment; Lifestyle; Quality of life; Randomised crossover study; Treatment satisfaction

Indexed keywords

INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; FEMALE; FOOD INTAKE; HUMAN; INSULIN TREATMENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; ANALYSIS OF VARIANCE; DIABETES MELLITUS; FACTOR ANALYSIS, STATISTICAL; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 0034466228     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008921419108     Document Type: Article

References (37)

1. Insulinabhängig...? Functional use of insulin
2. Empowering diabetes outpatients with structured education: Short-term and long-term effects of functional insulin treatment on perceived control over diabetes
3. Failure and efficacy of insulin therapy in insulin dependent (Type I) diabetic patients
4. Near-normoglycaemia and microvascular complications
5. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: The ADDQoL
6. [Lys(B28), Pro(B29)]-human insulin: A rapidly absorbed analogue of human insulin
7. Insulin Lispro: The first insulin analogue to reach the market
8. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients during insulin analog treatment
9. Mealtime treatment with insulin analog improves postprandial hyperglycemia hypoglycemia in patients with non insulin dependent diabetes mellitus
10. Health-related quality-of-life results from multinational clinical trials of insulin lispro
11. Psychological issues in clinical trial design
12. Measuring health changes among severely ill patients: The floor phenomenon
13. Understanding changes in health status: Is the floor phenomenon merely the last step of the staircase?
14. Comparing prospective and retrospective measures of treatment outcomes
15. Measures of psychological well-being and treatment satisfaction developed from the responses of people with tablet-treated diabetes
16. Psychometric evaluation of Diabetes Treatment Satisfaction Questionnaire in 8 languages
17. Well-being and treatment satisfaction in adults with diabetes: A Swedish population-based study
18. Algorithm adaptation under functional insulin treatment during transfer from regular to insulin lispro
19. Helsinki Recommendations guiding medical physicians in biomedical research involving human subjects (revised version)
20. ISO 9001 - Conformity in research, graduate education and rehabilitation
21. Associations between type of treatment and illness-specific locus of control in Type I diabetes patients
22. Methods for measuring patient satisfaction with specific medical encounters
23. Ceiling effect reduces the validity of the Diabetes Treatment Satisfaction Questionnaire
24. The Diabetes Treatment Satisfaction Questionnaire (DTSQ): Change version for use alongside status version provides appropriate solution where ceiling effects occur
25. A randomised controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy
26. Algorithms for adjustment of insulin dosage by patients who monitor blood glucose
27. Effects of the short-acting insulin analog [Lys(B28), Pro(B29)] on postprandial blood glucose control in IDDM
28. Insulin lispro in CSII. Results of a double-blind cross-over study
29. Severe hypoglycemia unawareness is associated with an early decrease in vigilance during hypoglycemia
30. Weak relationships between symptom perception and objective hypoglycaemia induced changes of autonomic function in hypoglycaemia unawareness in diabetes
31. Decrease of vigilance assessed by EEG-mapping in type I diabetic patients with history of recurrent severe hypoglycaemia
32. Diabetes Treatment Satisfaction Questionnaire (change) in English and German evaluated in insulin glargine trials